Share This

Public company info - YiChang HEC ChangJiang Pharmaceutical Co. Ltd. - H Shares , 01558.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. - H Shares, 01558.HK - Cash Flow 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12
Net Cash Flow from Operating Activities 1,552,024 2,135,561 926,494 760,116 448,999 343,998 146,910 60,838 98,209
Net Cash Flow from Return on Investments & Servicing of Finance -290,219 -721,842 -303,249 -306,073 -66,973 -23,024 -42,359 -48,966 -41,866
　Interest Received 24,987 36,038 14,601 14,737 8,104 2,172 242 513 346
　Interest Paid -95,216 -37,846 -1,434 -4,394 -7,454 -25,196 -42,601 -49,479 -42,212
　Dividend Received 0 0 0 0 0 0 0 0 0
　Dividend Paid -219,990 -720,034 -316,416 -316,416 -67,623 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -252,531 -341,154 -211,102 -89,365 -51,793 -56,604 -17,032 -9,292 -19,687
Net Cash Flow from Investing Activities -2,119,615 -1,746,521 -743,131 -627,108 -375,813 -345,747 -38,583 -73,131 -140,195
　Additions to Fixed Assets -994,159 -576,276 -620,039 -327,036 -62,987 -28,004 -35,470 -76,438 -140,238
　Disposal of Fixed Assets 19,619 4,537 0 367 0 5,257 73 3,307 43
　Increase in Investments 0 -78,159 0 -137,402 0 -33,000 0 0 0
　Decrease in Investments 0 0 0 0 0 0 -3,186 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 -30,091 173,881 -61,528 -122,667
　Others -1,145,075 -1,096,623 -123,092 -163,037 -312,826 -259,909 -173,881 61,528 122,667
Net Cash Flow before Financing Activities -1,110,341 -673,956 -330,988 -262,430 -45,580 -81,377 48,936 -70,551 -103,539
Net Cash Flow from Financing Activities 379,839 2,857,899 33,399 -50,656 -125,551 1,348,474 5,251 71,682 58,966
　New Loans 518,006 713,201 43,399 0 0 50,000 294,310 461,270 555,953
　Loans Repayment -1,250 -290,000 -10,000 -70,000 -105,000 -270,000 -462,940 -328,060 -374,320
　Fixed Income/Debt Instruments 0 2,680,657 0 0 0 1,613,481 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 19,344 1,984 -14,916 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 -30,091 173,881 -61,528 -122,667
　Others -136,917 -245,959 0 0 -22,535 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -730,502 2,183,943 -297,589 -313,086 -171,131 1,267,097 54,187 1,131 -44,573
Cash & Cash Equivalents at Beginning of Year 2,779,138 593,746 887,183 1,212,072 1,353,651 86,554 32,367 31,236 75,809
Net Cash Flow due to Change in Exchange Rate/Others -3,669 1,449 4,152 -11,803 29,552 0 0 0 0
Cash & Cash Equivalents at End of Year 2,044,967 2,779,138 593,746 887,183 1,212,072 1,353,651 86,554 32,367 31,236
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.